Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D.

Immunity. 2009 Apr 17;30(4):611. No abstract available.

2.

Retraction. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes.

Van Parijs L, Refaeli Y, Abbas AK, Baltimore D.

Immunity. 2009 Apr 17;30(4):612. No abstract available.

3.

Retraction. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens.

Van Parijs L, Peterson DA, Abbas AK.

Immunity. 2009 Apr 17;30(4):611. No abstract available.

4.

Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.

Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C.

Prostate. 2006 Feb 15;66(3):235-47.

PMID:
16173028
5.

Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.

Dillon CP, Sandy P, Nencioni A, Kissler S, Rubinson DA, Van Parijs L.

Annu Rev Physiol. 2005;67:147-73. Review.

PMID:
15709955
6.

Exploring the genetic basis of disease using RNA interference.

Kissler S, Van Parijs L.

Expert Rev Mol Diagn. 2004 Sep;4(5):645-51. Review.

PMID:
15347258
7.

Cre-lox-regulated conditional RNA interference from transgenes.

Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10380-5. Epub 2004 Jul 6.

8.

RNA interference for the identification of disease-associated genes.

Nencioni A, Sandy P, Dillon C, Kissler S, Blume-Jensen P, Van Parijs L.

Curr Opin Mol Ther. 2004 Apr;6(2):136-40. Review. Erratum in: Curr Opin Mol Ther. 2005 Jun;7(3):282.

PMID:
15195924
9.

A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells.

Hou WS, Van Parijs L.

Nat Immunol. 2004 Jun;5(6):583-9. Epub 2004 May 9.

PMID:
15133508
10.

Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.

Ballestrero A, Nencioni A, Boy D, Rocco I, Garuti A, Mela GS, Van Parijs L, Brossart P, Wesselborg S, Patrone F.

Clin Cancer Res. 2004 Feb 15;10(4):1463-70.

11.

The costimulation-regulated duration of PKB activation controls T cell longevity.

Song J, Salek-Ardakani S, Rogers PR, Cheng M, Van Parijs L, Croft M.

Nat Immunol. 2004 Feb;5(2):150-8. Epub 2004 Jan 18. Erratum in: Nat Immunol. 2004 Nov;5(11):1190. Nat Immunol. 2005 Feb;6(2):219.

PMID:
14730361
12.

Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.

Nencioni A, Lauber K, Gr√ľnebach F, Van Parijs L, Denzlinger C, Wesselborg S, Brossart P.

J Immunol. 2003 Nov 15;171(10):5148-56.

13.

Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.

Antov A, Yang L, Vig M, Baltimore D, Van Parijs L.

J Immunol. 2003 Oct 1;171(7):3435-41.

14.

Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1.

Layer K, Lin G, Nencioni A, Hu W, Schmucker A, Antov AN, Li X, Takamatsu S, Chevassut T, Dower NA, Stang SL, Beier D, Buhlmann J, Bronson RT, Elkon KB, Stone JC, Van Parijs L, Lim B.

Immunity. 2003 Aug;19(2):243-55. Retraction in: Immunity. 2012 May 25;36(5):886.

15.
16.

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L.

Nat Genet. 2003 Mar;33(3):401-6. Epub 2003 Feb 18. Erratum in: Nat Genet. 2003 Jun;34(2):231. Nat Genet. 2007 Jun;39(6):803. Zhang, Mingdi [added].

PMID:
12590264
17.

Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.

Shah AH, Tabayoyong WB, Kundu SD, Kim SJ, Van Parijs L, Liu VC, Kwon E, Greenberg NM, Lee C.

Cancer Res. 2002 Dec 15;62(24):7135-8.

18.

Small interfering RNA-mediated gene silencing in T lymphocytes.

McManus MT, Haines BB, Dillon CP, Whitehurst CE, van Parijs L, Chen J, Sharp PA.

J Immunol. 2002 Nov 15;169(10):5754-60.

19.

Interferon gamma is required for activation-induced death of T lymphocytes.

Refaeli Y, Van Parijs L, Alexander SI, Abbas AK.

J Exp Med. 2002 Oct 7;196(7):999-1005. Erratum in: J Exp Med. 2012 May 7;209(5):1049.

20.
21.
23.

IL-2 and related cytokines can promote T cell survival by activating AKT.

Kelly E, Won A, Refaeli Y, Van Parijs L.

J Immunol. 2002 Jan 15;168(2):597-603. Erratum in: J Immunol. 2007 Dec 15;179(12):8569.

24.

Retroviruses as tools to study the immune system.

Lois C, Refaeli Y, Qin XF, Van Parijs L.

Curr Opin Immunol. 2001 Aug;13(4):496-504. Review.

PMID:
11498308
25.

Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R.

Mol Cell Biol. 2000 Oct;20(20):7419-26.

26.
28.

Genetic models of abnormal apoptosis in lymphocytes.

Refaeli Y, Van Parijs L, Abbas AK.

Immunol Rev. 1999 Jun;169:273-82. Review.

PMID:
10450524
29.

Mechanisms of peripheral T cell tolerance.

van Parijs L, Perez VL, Abbas AK.

Novartis Found Symp. 1998;215:5-14; discussion 14-20, 33-40. Review.

PMID:
9760568
30.

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis.

Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK.

Immunity. 1998 May;8(5):615-23.

31.

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

Van Parijs L, Abbas AK.

Science. 1998 Apr 10;280(5361):243-8. Review.

PMID:
9535647
32.

Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice.

Van Parijs L, Sethna MP, Schweitzer AN, Borriello F, Sharpe AH, Abbas AK.

J Immunol. 1997 Dec 1;159(11):5336-44.

PMID:
9548473
33.

Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.

Van Parijs L, Biuckians A, Abbas AK.

J Immunol. 1998 Mar 1;160(5):2065-71.

35.

Role of interleukin 12 and costimulators in T cell anergy in vivo.

Van Parijs L, Perez VL, Biuckians A, Maki RG, London CA, Abbas AK.

J Exp Med. 1997 Oct 6;186(7):1119-28. Retraction in: J Exp Med. 2009 May 11;206(5):1207.

36.

Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor.

Van Parijs L, Biuckians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK.

J Immunol. 1997 Apr 15;158(8):3738-45.

PMID:
9103438
37.

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK.

Immunity. 1997 Apr;6(4):411-7.

38.

Role of Fas-mediated cell death in the regulation of immune responses.

Van Parijs L, Abbas AK.

Curr Opin Immunol. 1996 Jun;8(3):355-61. Review.

PMID:
8793992
39.

The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance.

Van Parijs L, Ibraghimov A, Abbas AK.

Immunity. 1996 Mar;4(3):321-8.

40.

Differentiation and tolerance of CD4+ T lymphocytes.

Abbas AK, Perez VL, Van Parijs L, Wong RC.

Ciba Found Symp. 1995;195:7-13; discussion 13-9. Review.

PMID:
8724827
41.

A negative regulatory function of B7 revealed in B7-1 transgenic mice.

Sethna MP, van Parijs L, Sharpe AH, Abbas AK, Freeman GJ.

Immunity. 1994 Aug;1(5):415-21.

PMID:
7533646
42.

Redefining health education in leprosy: a personal view.

Van Parijs LG.

Lepr Rev. 1990 Jun;61(2):97-111. Review. No abstract available.

PMID:
2198418
43.

Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction.

De Backer G, Hulstaert F, De Munck K, Rosseneu M, Van Parijs L, Dramaix M.

Am Heart J. 1986 Sep;112(3):478-84.

PMID:
3092607
44.

[Training of leprosy teams in health education].

Van Parijs LG.

Acta Leprol. 1986 Apr-Jun;4(2):187-90. French. No abstract available.

PMID:
3031918
45.

Public education in cancer prevention.

Van Parijs LG.

Bull World Health Organ. 1986;64(6):917-27.

46.

Public education in primary and secondary cancer prevention.

Van Parijs LG, Eckhardt S.

Hygie. 1984 Sep;3(3):16-28. No abstract available.

PMID:
6490014
47.

Reflections on the medical model and the objectives of health education.

Van Parijs L.

Int J Health Educ. 1980 Oct-Dec;23(4):205-15.

PMID:
7467862
48.

[Reflections on the possible role of health-insurance institutions in the area of health education].

van Parijs LG.

Soz Praventivmed. 1977 Nov;22(5):256-61. French. No abstract available.

PMID:
595906
49.

[Health education. Educational approach to change].

van Parijs LG.

Soz Praventivmed. 1977 Nov;22(5):212-9. French.

PMID:
595900
50.

Nothing to hide.

van Parijs LG.

J Psychiatr Nurs Ment Health Serv. 1976 Jun;14(6):33-4-39. No abstract available.

PMID:
178861

Supplemental Content

Loading ...
Support Center